| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1800129 | QL1604注射液 | iparomlimab | Injection | Biological Products(1) | New Drug Application | 2019-01-04 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | In Review | 2019-01-02 | view |
| CXSL2200257 | QL1604注射液 | iparomlimab | Injection | Biological Products(1) | New Drug Application | 2022-06-09 | QILU Pharmaceutical Co Ltd | view | |||
| CXSL2200049 | QL1604注射液 | iparomlimab | Injection | Biological Products(1) | New Drug Application | 2022-01-28 | QILU Pharmaceutical Co Ltd | view |